Palamedrix

Palamedrix is the first company to leverage DNA nanotechnology for revolutionary advancements in life sciences and medicine. By utilizing biosensors designed to capture small molecules present in biological samples, we can precisely pinpoint the presence of any analyte with single-molecule accuracy. The Palamedrix platform organizes biosensors using proprietary CMOS technology, providing doctors and patients with comprehensive data and a highly accurate, complete view of personal biochemistry through a single test. This extensive dataset offers biochemical insights for informed diagnosis and therapeutic intervention, ushering in a new era of data-driven healthcare.